Ignite Creation Date:
2025-12-24 @ 2:19 PM
Ignite Modification Date:
2026-02-21 @ 12:13 AM
Study NCT ID:
NCT02184195
Status:
COMPLETED
Last Update Posted:
2023-09-13
First Post:
2014-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-16
Start Date Type:
ACTUAL
Primary Completion Date:
2019-01-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-27
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-06
First Submit QC Date:
None
Study First Post Date:
2014-07-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-01-14
Results First Submit QC Date:
None
Results First Post Date:
2020-01-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-18
Last Update Post Date:
2023-09-13
Last Update Post Date Type:
ACTUAL